Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhengyuan Capsule for chemotherapy-related cancer-related fatigue in advanced unresectable non-small cell lung cancer
ChiCTR2000040061Phase 4Completed
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Nov 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Zhengyuan Capsule in cancer-related fatigue (CRF) (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: Brief Fatigue Inventory scale. Started Nov 2020; status: completed.
02
Drugs
Zhengyuan Capsule
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on ChiCTR2000040061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040061.